We are live on ! Find out more
VIVS icon

VivoSim Labs

30 hedge funds and large institutions have $1.24M invested in VivoSim Labs in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more capital inflows, than outflows

Capital inflows: $188K | Capital outflows: $123K

0.31% less ownership

Funds ownership: 16.19% → 15.89% (-0.31%)

9% less funds holding

Funds holding: 33 → 30 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

60% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 10

Holders
30
Holders Change
-3
Holders Change %
-9.09%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
10
Closed
6
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
-$5K

VIVS Hedge Fund Activity: Q3 2024 in Review

30 of the 6,989 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2024, worth a combined $1.24M — down 30% from $1.77M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VIVS and 3 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 4 added.

The largest buyer was Armistice Capital, adding an estimated $168K. The largest seller was Citadel Advisors, cutting an estimated $44.6K.

  • 30 institutional investors held VivoSim Labs (VIVS) as of Q3 2024, down from 33 in Q2 2024.
  • Funds reported $1.24M of VivoSim Labs stock for Q3 2024, down 30% quarter-over-quarter.
  • 3 funds opened new VivoSim Labs positions in Q3 2024 and 6 closed out, a net change of -3 holders.
  • The largest VivoSim Labs buyer in Q3 2024 was Armistice Capital, an estimated $168K added.
  • The largest VivoSim Labs seller in Q3 2024 was Citadel Advisors, an estimated $44.6K sold.

Based on aggregated 13F filings for Q3 2024.